Last reviewed · How we verify
Acute Moraxella catarrhalis bronchitis
Approved treatments
- Ceclor
- Ciprofloxacine · Poitiers University Hospital
- ALATROFLOXACIN · Pfizer
- Cefzil · Teva Pharmaceuticals USA
- Tomefloxacin · Otsuka
- Omnicef
- Vantin
- Sparcin
- Noroxin
- Floxin
- Dirythromycin
- Cipro · Bayer AG
- Biaxin · Generic (originally Abbott/AbbVie)
Clarithromycin is a macrolide antimicrobial drug. - Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute Moraxella catarrhalis bronchitis patent landscape — cliff calendar, originator estates, attackable patents
- Acute Moraxella catarrhalis bronchitis treatment landscape brief
- Acute Moraxella catarrhalis bronchitis treatment updates RSS
Frequently asked questions about Acute Moraxella catarrhalis bronchitis
What drugs treat Acute Moraxella catarrhalis bronchitis?
Tracked treatments include Ceclor, Ciprofloxacine, ALATROFLOXACIN, Cefzil, Tomefloxacin, Omnicef, Vantin, Sparcin.
What is the treatment for Acute Moraxella catarrhalis bronchitis?
Standard treatment for Acute Moraxella catarrhalis bronchitis includes Ceclor, Ciprofloxacine, ALATROFLOXACIN, Cefzil, Tomefloxacin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute Moraxella catarrhalis bronchitis patent cliff · Acute Moraxella catarrhalis bronchitis CI report
- Treatment: Ceclor
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: ALATROFLOXACIN · Pfizer
- Treatment: Cefzil · Teva Pharmaceuticals USA
- Treatment: Tomefloxacin · Otsuka
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing